HLB Co. Ltd (028300) - Net Assets
Based on the latest financial reports, HLB Co. Ltd (028300) has net assets worth ₩452.86 Billion KRW (≈ $306.90 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩703.48 Billion ≈ $476.74 Million USD) and total liabilities (₩250.62 Billion ≈ $169.84 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check HLB Co. Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩452.86 Billion |
| % of Total Assets | 64.37% |
| Annual Growth Rate | 23.94% |
| 5-Year Change | 20.18% |
| 10-Year Change | 581.12% |
| Growth Volatility | 77.77 |
HLB Co. Ltd - Net Assets Trend (2005–2024)
This chart illustrates how HLB Co. Ltd's net assets have evolved over time, based on quarterly financial data. Also explore HLB Co. Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for HLB Co. Ltd (2005–2024)
The table below shows the annual net assets of HLB Co. Ltd from 2005 to 2024. For live valuation and market cap data, see how much is HLB Co. Ltd worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩576.57 Billion ≈ $390.73 Million |
-0.97% |
| 2023-12-31 | ₩582.25 Billion ≈ $394.58 Million |
-8.73% |
| 2022-12-31 | ₩637.94 Billion ≈ $432.32 Million |
+46.33% |
| 2021-12-31 | ₩435.96 Billion ≈ $295.44 Million |
-9.13% |
| 2020-12-31 | ₩479.75 Billion ≈ $325.12 Million |
+159.48% |
| 2019-12-31 | ₩184.89 Billion ≈ $125.30 Million |
+5.84% |
| 2018-12-31 | ₩174.68 Billion ≈ $118.38 Million |
+126.15% |
| 2017-12-31 | ₩77.24 Billion ≈ $52.35 Million |
-12.97% |
| 2016-12-31 | ₩88.75 Billion ≈ $60.14 Million |
+4.84% |
| 2015-12-31 | ₩84.65 Billion ≈ $57.37 Million |
+267.72% |
| 2014-12-31 | ₩23.02 Billion ≈ $15.60 Million |
+48.49% |
| 2013-12-31 | ₩15.50 Billion ≈ $10.51 Million |
-16.67% |
| 2012-12-31 | ₩18.60 Billion ≈ $12.61 Million |
-12.21% |
| 2011-12-31 | ₩21.19 Billion ≈ $14.36 Million |
-9.07% |
| 2010-12-31 | ₩23.31 Billion ≈ $15.79 Million |
-49.84% |
| 2009-12-31 | ₩46.46 Billion ≈ $31.49 Million |
+7.26% |
| 2008-12-31 | ₩43.32 Billion ≈ $29.36 Million |
+123.57% |
| 2007-12-31 | ₩19.38 Billion ≈ $13.13 Million |
-0.31% |
| 2006-12-31 | ₩19.44 Billion ≈ $13.17 Million |
+98.91% |
| 2005-12-31 | ₩9.77 Billion ≈ $6.62 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to HLB Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 21193449096000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩211.93 Billion | 36.76% |
| Common Stock | ₩65.69 Billion | 11.39% |
| Other Components | ₩298.94 Billion | 51.85% |
| Total Equity | ₩576.57 Billion | 100.00% |
HLB Co. Ltd Competitors by Market Cap
The table below lists competitors of HLB Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Porsche Automobil Holding SE
F:PAHA
|
$5.41 Billion |
|
Firefly Aerospace Inc. Common Stock
NASDAQ:FLY
|
$5.41 Billion |
|
Yang Ming Marine Transport Corp
TW:2609
|
$5.41 Billion |
|
Bharat Dynamics Limited
NSE:BDL
|
$5.41 Billion |
|
Sundaram Finance Limited
NSE:SUNDARMFIN
|
$5.41 Billion |
|
Patanjali Foods Limited
NSE:PATANJALI
|
$5.40 Billion |
|
TECHNOLOGY ONE LTD.
F:RW8
|
$5.40 Billion |
|
Home BancShares Inc
NYSE:HOMB
|
$5.40 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in HLB Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 523,885,541,070 to 576,572,200,390, a change of 52,686,659,320 (10.1%).
- Net loss of 91,980,166,750 reduced equity.
- Share repurchases of 2,012,888,320 reduced equity.
- New share issuances of 2,012,888,320 increased equity.
- Other factors increased equity by 144,666,826,070.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-91.98 Billion | -15.95% |
| Share Repurchases | ₩2.01 Billion | -0.35% |
| Share Issuances | ₩2.01 Billion | +0.35% |
| Other Changes | ₩144.67 Billion | +25.09% |
| Total Change | ₩- | 10.06% |
Book Value vs Market Value Analysis
This analysis compares HLB Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.83x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 55.19x to 13.83x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1101.67 | ₩60800.00 | x |
| 2017-12-31 | ₩945.50 | ₩60800.00 | x |
| 2018-12-31 | ₩1980.23 | ₩60800.00 | x |
| 2019-12-31 | ₩1920.62 | ₩60800.00 | x |
| 2020-12-31 | ₩4539.18 | ₩60800.00 | x |
| 2021-12-31 | ₩4094.41 | ₩60800.00 | x |
| 2022-12-31 | ₩5222.63 | ₩60800.00 | x |
| 2023-12-31 | ₩4069.69 | ₩60800.00 | x |
| 2024-12-31 | ₩4396.90 | ₩60800.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently HLB Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -15.95%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -135.02%
- • Asset Turnover: 0.08x
- • Equity Multiplier: 1.54x
- Recent ROE (-15.95%) is below the historical average (-13.30%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -12.22% | -7.88% | 0.69x | 2.26x | ₩-5.33 Billion |
| 2015 | 14.93% | 32.86% | 0.21x | 2.19x | ₩4.17 Billion |
| 2016 | -14.89% | -43.85% | 0.16x | 2.10x | ₩-22.09 Billion |
| 2017 | -21.40% | -71.85% | 0.12x | 2.44x | ₩-24.25 Billion |
| 2018 | 14.51% | 70.04% | 0.12x | 1.74x | ₩7.87 Billion |
| 2019 | -24.01% | -115.53% | 0.11x | 1.96x | ₩-62.88 Billion |
| 2020 | -16.69% | -142.57% | 0.08x | 1.47x | ₩-128.07 Billion |
| 2021 | -22.51% | -140.53% | 0.09x | 1.71x | ₩-141.72 Billion |
| 2022 | -12.25% | -43.49% | 0.19x | 1.52x | ₩-141.95 Billion |
| 2023 | -35.80% | -437.17% | 0.06x | 1.43x | ₩-239.94 Billion |
| 2024 | -15.95% | -135.02% | 0.08x | 1.54x | ₩-149.64 Billion |
Industry Comparison
This section compares HLB Co. Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $228,568,731,314
- Average return on equity (ROE) among peers: 4.45%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| HLB Co. Ltd (028300) | ₩452.86 Billion | -12.22% | 0.55x | $5.41 Billion |
| ORIENTBIO Inc. (002630) | $85.10 Billion | 15.13% | 0.14x | $43.15 Million |
| Green Cross (005250) | $221.73 Billion | 2.76% | 8.07x | $425.10 Million |
| Green Cross Holdings Preference Shares (005257) | $1.44 Trillion | 3.01% | 0.78x | $3.74 Million |
| Pharmicell (005690) | $76.66 Billion | 10.78% | 0.43x | $736.42 Million |
| GeneOne Life Science Inc (011000) | $26.74 Billion | 0.00% | 0.49x | $49.94 Million |
| Daesung Microbiological Labs. Co. Ltd (036480) | $30.30 Billion | 5.14% | 0.15x | $19.29 Million |
| Seoulin Bioscience Co.Ltd (038070) | $53.72 Billion | 4.89% | 0.32x | $37.92 Million |
| Hyundai Bioscience Co. Ltd (048410) | $58.24 Billion | 3.27% | 0.77x | $872.13 Million |
| iNtRON Biotechnology Inc (048530) | $64.96 Billion | -4.91% | 0.37x | $77.34 Million |
About HLB Co. Ltd
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, inclu… Read more